Sonic Healthcare USA
Paolo Cotzia serves as the Medical Director of Molecular Pathology and the Head of Molecular Excellence at Sonic Healthcare USA, having previously held roles as the Medical Director and Laboratory Director at Sonic Reference Laboratory. Prior experience includes positions as Assistant Professor of Pathology and Assistant Director of the Center for Biospecimen Research and Development at NYU Langone Health, as well as M.D. Fellowships in Molecular Pathology and Oncologic Surgical Pathology at Memorial Sloan Kettering Cancer Center. Early career development involved serving as Chief Resident in Pathology at Thomas Jefferson University Hospitals and completing M.D. residencies and research fellowships. Paolo Cotzia obtained a Doctor of Medicine degree from Università degli Studi di Milano.
This person is not in the org chart
Sonic Healthcare USA
1 followers
Sonic Healthcare USA is a subsidiary of Sonic Healthcare Limited, one of the world's largest medical diagnostics companies, providing laboratory services to medical practitioners, hospitals and community health services, with operations in eight countries, on three continents and providing care to over 120 million patients each year. Sonic Healthcare USA is a leading provider of state-of-the-art laboratory services and professional pathology groups throughout the USA with nine operating divisions and nearly eight thousand US-based employees. Sonic Healthcare USA utilizes a federated business model that emphasizes medical leadership and community-based laboratory testing and professional pathology services to provide outstanding quality and service to the doctors and patients that they serve. For more information, visit the Sonic Healthcare website at www.sonichealthcareusa.com.